Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome

Pediatrix92 enrolled

Overview

The purpose of the study is to provide comprehensive follow-up in patients with Long QT Syndrome (LQTS) and gain additional information regarding genotype-phenotype correlation and effective management and treatment options.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Long QT Syndrome

Eligibility

Sex: ALLMax age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children and/or young adults diagnosed with heterogeneous repolarization disorder who have genotype positive Long QT, or * Newly diagnosed mutation positive patients with a confirmed test Exclusion Criteria: * Children who are phenotypically positive with no molecular testing * Children that are phenotypically positive but genotype negative

Locations (1)

Children's Cardiology Associates

Austin, Texas, United States

Outcomes

Primary Outcomes

Adverse Cardiac Events on patients with genotype positive LQT1 who have a normal EKG and absence of symptoms, but a molecular confirmation of LQT1.

Time frame: Enrollment is expected to take approximately 5 years. The patients will be followed until they are no longer cared for by a pediatric cardiology facility (typically post-college) or approximately 21 years of age.

Secondary Outcomes

Adverse Cardiac Events on patients with both phenotype and genotype positive.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.